The High Prevalence Of Chronic Diseases Along With Government Funding Drives The Cell Isolation Market

What is cell isolation?

Cell isolation is also termed cell separation. It is the process of obtaining a cell sample from available tissue, blood, or any biological samples. Cell isolation determines the type of cell and its characterizations. It is a widely used technique for the development of various biopharmaceuticals such as recombinant proteins, biosimilars, or monoclonal antibodies. It involves techniques such as density gradient centrifugation, fluorescence-activated cell sorting (FACS), and magnetic-activated cell sorting (MACS). Cell isolation has various applications in biologics designing, in-vitro diagnostics, research applications, and therapeutic protein production. 

Here are some driving factors that affect the growth of the cell isolation market:

Increased government funding for cell-based research

Cell isolation is an important aspect of cell-based treatments. Hence, several government bodies across the globe have funded such research activities. For instance, the National Institutes of Health (NIH) announced the award of USD 30 million in grants to support all the research activities for developing new tools and technologies in cell-based studies. Multiple institutions like the University of California San Francisco, Harvard University, and others were funded under this award. There, such funding is expected to drive the cell-isolation market across the globe. 

Growing prevalence of chronic diseases 

Chronic diseases like diabetes, cancer, and heart disease are on the rise across the globe. Similarly, the rising prevalence of infectious diseases like malaria, HIV, dengue, and tuberculosis are also contributing significantly to the market growth of cell isolation. As per the study of Imperial College London, in 2020, seven out of ten fatalities across the globe were expected to be due to chronic diseases. These chronic illnesses accounted for over 41 million deaths annually. Therefore, the need for cellular therapies or cell-based technologies to treat chronic diseases is increased along with the prevalence of chronic diseases. Thus, with an increase in cellular research activities, the market for cell separation technologies is expected to grow at a higher rate. 

Restraining factor:

Lack of skilled professionals 

The lack of skilled professionals is a major factor in the cell isolation market. Research institutions and clinical laboratories play a very significant role in this market. Major importance is given to the safety, accuracy, and timeliness of the cell separation process. Moreover, a lack of awareness about cell separation and its techniques in healthcare institutions and laboratories leads to complications and inefficient work. Research institutions need to train people about the rising technological advancements and help them to adopt these techniques for the isolation process. Therefore, the lack of skilled professionals and technicians can hinder the market growth of the cell isolation process. 

Recent development:

In October 2022,

Thermo Fisher Scientific, Inc. launched DynaCellect

Gibco CTS Dynacellect Magnetic Separation System is a closed automated isolation system. It helps in the activation and bead removal system for cell therapy development and manufacturing. It optimizes the cell therapy process. 

Conclusion: 

The increased government funding for cell-based research with the prevalence of chronic diseases is seen to drive the market growth of the cell isolation process. Furthermore, growing technological advancements in the cell separation process will enhance its automation and development. Thus, increasing the market share of the cell isolation market.

Anushka Gore  

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behavio…